nifedipine and n-(1-methylethyl)-1,1,2-trimethylpropylamine

nifedipine has been researched along with n-(1-methylethyl)-1,1,2-trimethylpropylamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, Y; Li, GH; Lin, YF; Liu, Q; Mao, X; Misaki, N; Suga, S; Wakui, M; Wang, H; Wu, J	1

Other Studies

1 other study(ies) available for nifedipine and n-(1-methylethyl)-1,1,2-trimethylpropylamine

Article	Year
Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release. The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:2 Topics: Animals; Calcium; Cell Line; Cells, Cultured; Diazoxide; Dose-Response Relationship, Drug; Female; Glucose; Humans; Insulin; Insulin-Secreting Cells; Ion Channel Gating; KATP Channels; Membrane Potentials; Nifedipine; Oocytes; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Propylamines; Rats; Tolbutamide; Xenopus laevis	2007

Article

Year

Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.

The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:2

Topics: Animals; Calcium; Cell Line; Cells, Cultured; Diazoxide; Dose-Response Relationship, Drug; Female; Glucose; Humans; Insulin; Insulin-Secreting Cells; Ion Channel Gating; KATP Channels; Membrane Potentials; Nifedipine; Oocytes; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Propylamines; Rats; Tolbutamide; Xenopus laevis

2007